Capital continues to flow into MedTech M&A as companies pursue AI-driven solutions to streamline administrative tasks and drive improved patient outcomes.
In a recent interview with Citeline for the article “Industry Experts Expect AI-Driven MedTech M&A to Continue in 2025,” PMCF Investment Banking Managing Director Bryan Hughes highlighted the continued shift.
Hughes, who leads the firm’s Healthcare and MedTech verticals, said both strategic buyers and private equity investors are looking toward platforms that can integrate AI and deliver measurable value. This value is driven by scalable platforms that can be implemented, often for larger strategics or investors, he said.
“Typically, those companies don’t have the resources internally” to create and implement their own holistic solutions to drive better outcomes, Hughes told Citeline.
Recently, Hughes and PMCF Vice President Mike Brooks authored “How Artificial Intelligence is Rewriting the Playbook for Healthcare M&A,” including insights on MedTech, clinical, administrative, and analytics.
“Sellers with integrated AI-solutions have commanded aggressive valuations, with buyers seeking high-growth, capital-efficient companies,” Hughes and Brooks wrote.
To read the Citeline article (subscription required), click here
To read “How Artificial Intelligence is Rewriting the Playbook for Healthcare M&A,” click here
